Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Mylan Inc (MYL)

2015-01-30@17:11:19 ET
SmarTrend Watching for Potential Rebound in Shares of Mylan After 3.16% Loss (PSM)

2015-01-30@17:10:49 ET
After Yesterday's Decline of 3.16%, Mylan Offers Investors Better Value (PSM)

2015-01-30@08:58:08 ET
Mylan Laboratories (MYL) Trading Near $55.61 Resistance Level (FBM)

2015-01-29@11:18:00 ET
Mylan Shareholders Overwhelmingly Approve Agreement Implementing Acquisition of Abbott's Non-U.S. Developed Markets Specialty and Branded Generics Business (PRN)

2015-01-29@04:48:31 ET
Gilead expands hepatitis C generic licensing agreements to include investigational NS5A inhibitor GS-5816 (ABW)

2015-01-28@16:17:41 ET
Mylan Expands Pact With Gilead For HEP-C Drug (ABW)

2015-01-28@09:38:41 ET
Mylan expands Hepatitis C licensing agreement with Gilead (ABW)

2015-01-28@06:34:03 ET
Mylan to include investigational Pan-Genotypic Agent Hepatitis C single tablet under expanded licensing agreement with Gilead (MTO)

2015-01-27@21:29:22 ET
Mylan, IncCorporate Event Announcement Notice (WSH)

2015-01-27@13:59:34 ET
Mylan Laboratories (MYL) Showing Resistance Near $58.97 (FBM)

2015-01-26@22:05:42 ET
Mylan, IncCorporate Event Announcement Notice (WSH)

2015-01-26@21:05:39 ET
Mylan, IncCorporate Event Announcement Notice (WSH)

2015-01-26@17:01:16 ET
After Yesterday's Rally of 4.78% Shares Could Potentially Pullback (PSM)

2015-01-26@17:00:46 ET
Mylan Set to Possibly Pullback After Yesterday's Rally of 4.78% (PSM)

2015-01-26@16:35:07 ET
Mylan Laboratories (MYL) Showing Support Near $53.20 (FBM)

2015-01-26@10:58:00 ET
Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent (PRN)

2015-01-23@12:17:18 ET
Potential Mylan Laboratories (MYL) Trade Has 3.56% Downside Protection (FBM)

2015-01-22@10:03:11 ET
Mylan Laboratories (MYL) Showing Bearish Technicals (FBM)

2015-01-21@08:30:25 ET
Bottom 5 Companies in the Pharmaceuticals Industry with the Lowest Relative Performance (DEPO, JNJ, NKTR, MYL, MDCO) (F70)